◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › ISRG

Intuitive Surgical Inc (ISRG) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-07-12

Intuitive Surgical Inc (ISRG) operates in the Health Care Equipment industry and is headquartered in Sunnyvale, United States with about 17,021 employees. Its market capitalization is roughly $121 billion. In the fiscal year ended 2025-12-31, ISRG reported $10.1B in revenue and $2.9B in net income.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.

Interactive charts & full statements → Open the ISRG valuation workbench →

ISRG Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$10.6B	$10.1B	$8.4B	$7.1B	$6.2B	$5.7B	$4.4B	$4.5B	$3.7B	$3.1B	$2.7B	$2.4B	$2.1B	$2.3B	$2.2B	$1.8B	$1.4B	$1.1B	$875M	$601M	$373M
Gross Profit	$7.0B	$6.6B	$5.6B	$4.7B	$4.2B	$4.0B	$2.9B	$3.1B	$2.6B	$2.2B	$1.9B	$1.6B	$1.4B	$1.6B	$1.6B	$1.3B	$1.0B	$751M	$621M	$414M	$248M
Gross Margin %	66.3%	66.0%	67.5%	66.4%	67.4%	69.3%	65.6%	69.5%	69.9%	70.1%	69.9%	66.2%	66.3%	70.4%	72.1%	72.5%	72.9%	71.4%	71.0%	69.0%	66.5%
Operating Income (EBIT)	$3.2B	$2.9B	$2.3B	$1.8B	$1.6B	$1.8B	$1.1B	$1.4B	$1.2B	$1.1B	$945M	$740M	$545M	$852M	$878M	$695M	$555M	$377M	$311M	$207M	$107M
Operating Margin %	30.4%	29.3%	28.1%	24.8%	25.4%	31.9%	24.1%	30.7%	32.2%	33.7%	34.9%	31.0%	25.6%	37.6%	40.3%	39.5%	39.3%	35.9%	35.5%	34.4%	28.8%
Net Income	$3.0B	$2.9B	$2.3B	$1.8B	$1.3B	$1.7B	$1.1B	$1.4B	$1.1B	$660M	$736M	$589M	$419M	$671M	$657M	$495M	$382M	$233M	$204M	$145M	$72M
Net Margin %	28.1%	28.4%	27.8%	25.2%	21.2%	29.8%	24.3%	30.8%	30.3%	21.1%	27.2%	24.7%	19.7%	29.6%	30.1%	28.2%	27.0%	22.1%	23.4%	24.1%	19.3%
EBITDA	$4.3B	$4.0B	$3.1B	$2.4B	$2.0B	$2.1B	$1.3B	$1.6B	$1.3B	$1.2B	$1.0B	$830M	$619M	$920M	$936M	$741M	$596M	$412M	$336M	$220M	$143M
Earnings Per Share (EPS)	$8.24	$7.87	$6.42	$5.03	$3.65	$4.66	$2.94	$3.85	$3.16	$1.89	$2.08	$1.73	$1.23	$1.86	$1.78	$1.37	$1.05	$0.66	$0.57	$0.41	$0.21
Shares Outstanding (M)	360M	363M	362M	357M	362M	366M	361M	359M	356M	349M	354M	341M	339M	361M	370M	362M	363M	353M	359M	351M	343M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ISRG Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$2.8B	$2.9B	$2.5B	$2.4B	$2.3B	$2.4B	$2.0B	$2.0B
Gross Profit	$1.8B	$1.9B	$1.7B	$1.6B	$1.5B	$1.6B	$1.4B	$1.4B
Gross Margin %	66.1%	66.4%	66.4%	66.3%	64.7%	68.0%	67.4%	68.3%
Operating Income (EBIT)	$855M	$864M	$760M	$743M	$578M	$735M	$577M	$567M
Operating Margin %	30.9%	30.1%	30.3%	30.5%	25.7%	30.4%	28.3%	28.2%
Net Income	$822M	$795M	$704M	$658M	$698M	$686M	$565M	$527M
Net Margin %	29.6%	27.7%	28.1%	27.0%	31.0%	28.4%	27.7%	26.2%
EBITDA	$1.1B	$1.2B	$1.0B	$987M	$809M	$934M	$787M	$766M
Earnings Per Share (EPS)	$2.28	$2.21	$1.95	$1.81	$1.92	$1.88	$1.56	$1.46
Shares Outstanding (M)	360M	360M	362M	364M	365M	364M	363M	361M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ISRG Free Cash Flow History

Cash flow	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$3.4B	$3.0B	$2.4B	$1.8B	$1.5B	$2.1B	$1.5B	$1.6B	$1.2B	$1.1B	$1.0B	$772M	$665M	$880M	$814M	$678M	$528M	$385M	$278M	$206M	$100M
Capital Expenditures (CapEx)	$526M	$540M	$1.1B	$1.1B	$532M	$354M	$342M	$426M	$187M	$191M	$54M	$81M	$106M	$105M	$142M	$83M	$96M	$53M	$106M	$24M	$18M
Free Cash Flow (FCF)	$2.8B	$2.5B	$1.3B	$750M	$958M	$1.7B	$1.1B	$1.2B	$982M	$953M	$989M	$691M	$560M	$775M	$672M	$595M	$432M	$332M	$172M	$182M	$82M
FCF Margin %	26.8%	24.8%	15.6%	10.5%	15.4%	30.4%	26.2%	26.2%	26.4%	30.5%	36.6%	29.0%	26.2%	34.2%	30.9%	33.8%	30.6%	31.5%	19.7%	30.2%	21.9%
Dividends Paid	—	—	$8M	—	—	—	—	—	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ISRG Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$912M	$892M	$841M	$715M	$582M	$823M	$706M	$620M
Capital Expenditures (CapEx)	$103M	$162M	$105M	$155M	$117M	$312M	$248M	$309M
Free Cash Flow (FCF)	$809M	$730M	$736M	$560M	$465M	$511M	$459M	$311M
FCF Margin %	29.2%	25.5%	29.4%	22.9%	20.6%	21.2%	22.5%	15.5%
Dividends Paid	—	—	—	—	—	—	$8M	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ISRG Balance Sheet History

Balance sheet	2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$20.1B	$20.6B	$18.8B	$15.4B	$13.0B	$13.6B	$11.2B	$9.7B	$7.8B	$5.8B	$6.5B	$4.9B	$4.0B	$4.0B	$4.1B	$3.1B	$2.4B	$1.8B	$1.5B	$1.0B	$672M
Cash & Cash Equivalents	$2.0B	$3.4B	$2.0B	$2.8B	$1.6B	$1.3B	$1.6B	$1.2B	$858M	$3.8B	$4.8B	$3.3B	$2.5B	$782M	$554M	$2.2B	$1.6B	$1.2B	$195M	$123M	$34M
Total Liabilities	$2.5B	$2.7B	$2.3B	$2.0B	$1.9B	$1.6B	$1.4B	$1.4B	$1.2B	$1.0B	$709M	$588M	$580M	$449M	$479M	$418M	$353M	$272M	$208M	$151M	$82M
Total Debt (Short + Long-Term)	$0M	$39M	$34M	$25M	$24M	$20M	$22M	$569M	$39M	$372M	$144M	$103M	$81M	$5M	$83M	$96M	$78M	$69M	$0M	$0M	$0M
Total Shareholders' Equity	$17.5B	$17.8B	$16.4B	$13.3B	$11.0B	$12.0B	$9.8B	$8.3B	$6.7B	$4.7B	$5.8B	$4.3B	$3.4B	$3.5B	$3.6B	$2.6B	$2.0B	$1.5B	$1.3B	$889M	$590M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ISRG viewer.

Other Companies in Health Care Equipment

ABT · Abbott Laboratories — $180 billion
SYK · Stryker Corporation — $127 billion
MDT · Medtronic — $107 billion
BSX · Boston Scientific — $66 billion
EW · Edwards Lifesciences — $48 billion
BDX · Becton Dickinson — $43 billion
IDXX · Idexx Laboratories — $43 billion
RMD · ResMed — $28 billion

← ISPR All stocks ISSC →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.